Oncogenic Ras induces premature senescence in primary cells. Such an oncogene-induced senescence involves activation of tumor suppressor genes that provide a checkpoint mechanism against malignant transformation. In mouse, the ARF-p53 pathway mediates Ha-Ras
Introduction
The mammalian Ras proto-oncogene family comprises Ha-Ras, Ki-Ras, and N-Ras, encoding 21 kDa GTPbinding proteins with intrinsic GTPase activity, which serves as a key molecular switch for signal transduction from activated receptor tyrosine kinases, such as epidermal growth factor receptor. Mutations of Ras at codons 12, 13, and 61, frequently found in human cancers and experimental cancer models, render Ras constitutively active by decreasing its GTPase activity (Barbacid, 1987; Bos, 1989) .
Oncogenic mutant Ras has been shown to transform NIH3T3 and also cell lines immortalized by oncogenes or carcinogens (Newbold and Overell, 1983; Franza et al., 1986; Weinberg, 1989 Weinberg, , 1997 Ruley, 1990) . However, it fails to transform primary human cells, and instead prematurely induces cell-cycle arrest and morphological and biochemical changes characteristic of senescent cells before they undergo replicative senescence consistent with Hayflick's limitation (Serrano et al., 1997) . Extensive studies have been carried out in primary mouse embryonic fibroblasts and mouse epidermal keratinocytes to elucidate mechanisms underlying the ability of oncogenic mutant Ras (Ha-Ras G12V ) to induce premature senescence (Serrano et al., 1997; Lin et al., 1998; Palmero et al., 1998; Pearson et al., 2000; Lin and Lowe, 2001; Ferbeyre et al., 2002) .
In rodent cells, ectopically expressed Ha-Ras
G12V
-induced premature senescence is associated with accumulation of p53, p19 ARF , p21 WAF1 , and p16
INK4a
, with hypophosphorylation of the retinoblastoma protein (pRb) and subsequent cell-cycle arrest (Serrano et al., 1997) . Moreover, studies using knockout mice have revealed that the p19 ARF -p53 pathway plays an essential role in Ha-Ras G12V -induced premature senescence, and that disruption of either p19 ARF or p53 is sufficient to transform mouse epidermal keratinocytes (Lin and Lowe, 2001) . By contrast, Ras fails to transform Cdk4 À/À mouse embryonic fibroblasts and induces ARF/p53-independent senescence, while pRb inactivation coupled with Ras activation transforms Cdk4 À/À cells (Zou et al., 2002) . This underscores the importance of the pRb pathway in Ras-induced senescence (Zou et al., 2002) . However, p16 INK4a is not required for Ha-Ras G12V -induced premature senescence as p16 INK4a deficient mouse embryonic fibroblasts still undergo senescence and are arrested by oncogenic Ras (Krimpenfort et al., 2001; Sharpless et al., 2001) .
Ha-Ras G12V also induces premature senescence in primary human fibroblasts (Serrano et al., 1997) . However, in human fibroblasts, Ha-Ras G12V does not induce p14
ARF (Wei et al., 2001) , and ectopic expression of dominant-negative p53 does not prevent cells from undergoing senescence (Serrano et al., 1997) . Interestingly, human diploid fibroblasts devoid of p16
INK4a are resistant to Ras-induced senescence and acquire anchorage independence Huot et al., 2002) . Furthermore, cyclin-dependent kinase 4 (Cdk4) cooperates with Ha-Ras G12V to transform human epidermal keratinocytes (Lazarov et al., 2002) . Recently, we observed that Ha-Ras G12V transduction in hTERTimmortalized human esophageal epithelial cells results in senescence with p16
INK4a induction, and that ectopic expression of p16
INK4a alone induced senescence in these cells . These studies indicate that the pRb pathway is a critical target for oncogenic Rasinduced senescence in human cells. However, the role of the ARF-p53 pathway in Ras-induced senescence has not been examined in human epithelial cells with limited analysis restricted to fibroblasts. In this study, we have established that p53 may be dispensable for oncogenic Ras-mediated senescence in primary as well as hTERTimmortalized human esophageal keratinocytes.
Results

Ha-Ras
G12V induces senescence in human esophageal keratinocytes regardless of the p53 status
We have previously characterized primary human esophageal epithelial cells, EPC1 and EPC2, that retain functionally normal p53 and pRb pathways . In order to study the role of p53 in Ha-Ras G12V -mediated senescence in primary human esophageal keratinocytes; EPC1, EPC2; and the immortalized derivative EPC2-hTERT, these cell lines were stably transduced with dominant-negative versions of p53 (p53 V143A and p53 R175H ). P53 was expressed in a robust fashion in the dominant-negative p53-transduced cells (Figures 1 and 5a and b). Hydroxyurea and ultraviolet failed to induce p21 WAF1 and Bax by 24 h in these cells, implying impaired p53 function in response to genotoxic stress (Figure 1b and c, and data not shown). Although a modest induction of both p21
WAF1
and Bax was observed 48 h after hydroxyurea treatment, a p53-independent mechanism may also be responsible for the induction as described previously (Johnson et al., 1994; Russo et al., 1995; Haapajarvi et al., 1999; Suliman et al., 2001; Gadducci et al., 2002; Concin et al., 2003; Suzuki et al., 2003) . We next transduced cells with a retrovirus expressing Ha-Ras G12V , typically inducing 5-10-fold higher levels of Ras protein expression than empty vector (pBabe-zeo)-transduced control cells (Figure 5a and b) , and increased Ras activities measured as a Raf-binding form (data not shown) within 36 h after infection. When EPC2 cells were transduced at eight population doublings (PDs) with Ha-Ras
G12V
, 50-60% of cells underwent morphological changes with flat and enlarged cytoplasm within 6 days after retroviral infection, while no changes were observed in control cells transduced with an empty vector (Figure 2a and b) . About 30-40% of the Ha-Ras G12V -transduced cells were positive for senescenceassociated b-galactosidase activity (SABG) 2 weeks after infection followed by selection with zeocin for 4 days (Figure 2c ). Furthermore, Ha-Ras G12V transduction resulted in growth arrest as corroborated by decreased DNA synthesis (Figure 2d ). These data indicate that Ha-Ras G12V induces premature senescence in EPC2 cells. While inactivation of either p19 ARF or p53 is sufficient for mouse skin keratinocytes not only to escape Ha-Ras G12V -induced premature senescence but also to undergo transformation (Weinberg et al., 1994; Lin and Lowe, 2001) , it remains undetermined whether p53 dysfunction affects Ha-Ras transduction (data not shown). These observations with primary human esophageal keratinocytes were in contrast to the consequences of Ras activation in mouse esophageal keratinocytes where a p53 À/À state but not wild-type p53 permitted cells to overcome Ha-Ras G12V -induced senescence (Figure 3b-d) . Moreover, p53 À/À mouse esophageal keratinocytes, but not wild-type mouse esophageal keratinocytes, formed colonies in soft agar upon Ha-Ras G12V transduction (data not shown). As several p53 mutants, including p53 V143A and p53 R175H , have been found to harbor oncogenic properties in addition to their dominant-negative effects of the wildtype p53 tumor suppressor functions (Sigal and Rotter, 2000; van Oijen and Slootweg, 2000) , it is possible that abrogation of p53 function by these p53 mutants is not functionally equivalent to the p53-null status. Therefore, we transduced p53 R175H into both wild-type and p53 Ras-induced senescence in human esophageal keratinocytes M Takaoka et al not shown). Therefore, p53 does not appear to play a role in Ha-Ras G12V -induced premature senescence in primary human esophageal keratinocytes.
Ectopic expression of hTERT does not prevent
Ha-Ras
G12V
-induced senescence Next, we aimed to assess the consequence of Ras activation in hTERT-immortalized primary human esophageal keratinocytes, designated as EPC2-hTERT, expressing either dominant-negative p53 (p53 R175H ) or a control empty vector (pBabe-puro). We hypothesized that constitutively active telomerase in mouse epithelial cells may contribute to Ha-Ras G12V -mediated cellular transformation when the ARF-p53 pathway is inactivated. As described previously, EPC2-hTERT cells express constitutively active telomerase and have extended telomeres without genetic or epigenetic abnormalities in the p53 and pRb pathways . We used EPC2-hTERT cells at 150-170 PDs for experiments carried out in this study. As shown in Figure 4 , EPC2-hTERT cells underwent senescence upon Ha-Ras G12V transduction regardless of p53 status. The Ha-Ras G12V -transduced immortalized cells remained quiescent in culture for at least 2 weeks after retroviral infection and did not form colonies in soft agar (data not shown). These data suggest that neither telomere length nor telomerase activity antagonizes the Ha-Ras G12V -induced senescence even if p53 mediated functions are disrupted.
pRb but not ARF-p53 pathway is the key target for Ha-Ras G12V -induced senescence in human esophageal keratinocytes Finally, we determined expression of cell cycle regulatory molecules upon Ras activation in primary human and mouse esophageal keratinocytes. Consistent with apparent growth arrest and inhibition of DNA synthesis observed in Ha-Ras G12V -transduced cells (Figures 2d and  4c) , the most remarkable changes appeared to be reduction of the hyperphosphorylated form of pRb by 60-80% and 2-3-fold induction of p16
INK4a regardless of the p53 status in human esophageal keratinocytes within 6 days after retroviral infection (Figure 5a and b) . Such changes were also observed in wild-type mouse esophageal keratinocytes upon Ha-Ras G12V transduction (Figure 5c) as described previously (Serrano et al., 1997; Lin et al., 1998; Wei et al., 2001) . By contrast, Ha-Ras G12V failed to suppress the hyperphosphorylated form of pRb in mouse esophageal keratinocytes with impaired p53 functions (Figure 5c and data not shown), while such cells escaped senescence (Figure 3a-d) . Consistent with previous observations in human epi- Cdk6 by 20-40% and cyclin D1 by 50% was also found. By contrast, Ha-Ras G12V did not affect the levels of p53 and p21 WAF1 even in parental EPC2 cells expressing wildtype p53 (Figure 5a ). On the other hand, a mild upregulation of p53 by 50% and p21 WAF1 by 30% was detected in Ha-Ras
-transduced EPC2-hTERT that harbor wild-type p53 (Figure 5b) . Importantly, p14 ARF did not appear to be upregulated in human esophageal keratinocytes upon Ras activation.
Discussion
The mechanisms underlying oncogenic Ras-induced senescence have been extensively studied in mouse and human fibroblasts (Serrano et al., 1997; Lin et al., 1998; Palmero et al., 1998; Pearson et al., 2000; Ferbeyre et al., 2002) . While a cell-type specific or species-specific difference in response to oncogenic Ras activation has been observed in both the p16
INK4a
-pRb and ARF-p53 pathways, it is not clear what role p53 has in primary human epithelial cells. We have demonstrated that primary human esophageal keratinocytes, unlike their mouse counterparts, do not employ the ARF-p53 pathway to trigger or maintain senescence upon oncogenic Ras activation.
We observed a senescence phenotype regardless of the p53 status not only in primary human esophageal keratinocytes but also in hTERT-immortalized human esophageal keratinocytes. The immortalized cells express constitutively active telomerase, which prevents shortening of telomere lengths during chromosomal DNA replication. It should be emphasized that Rasinduced senescence is distinct from replicative senescence, where telomere attrition is thought to trigger a p53 response. Consistent with this notion, we did not observe any delay in appearance of a senescence phenotype upon Ha-Ras G12V transduction in human esophageal keratinocytes that express dominant-negative mutant p53. By contrast, ectopically expressed dominant-negative p53 extends the replicative lifespan of primary human esophageal (Takaoka, Nakagawa, and Rustgi, unpublished observations) and oral keratinocytes (Opitz et al., 2002) , suggesting that p53 is activated when primary oral and esophageal keratinocytes undergo replicative senescence. In the absence of functional p53, it is conceivable that other p53 family members may compensate for p53 function. p63 can transactivate the p21 WAF1 promoter in p53 À/À esophageal keratinocytes (Suliman et al., 2001) . However, this is unlikely to account for Ha-Ras G12V -induced senescence in human esophageal keratinocytes expressing dominant-negative p53, because neither p21 WAF1 nor p63 is upregulated in Ha-Ras -mediated senescence (Serrano et al., 1997) . Recent evidence in mouse systems underscores the importance of the level of activated Ras in mediating transformation or cell-cycle arrest (Fisher et al., 2001; Guerra et al., 2003; Hingorani et al., 2003; Schreiber et al., 2004; Tuveson et al., 2004) . Therefore, we cannot exclude the possibility that the oncogenic Ras activity achieved in this study may exceed the level that can transform the cells in concert with impaired p53 functions even in human cells. In our experimental conditions, however, dominant-negative p53 did not prevent Ha-Ras
G12V
-induced senescence when we used the minimal viral titer that rendered the human esophageal keratinocytes resistant to selective antibiotics (data not shown).
Experiments in human fibroblasts reveal that in spite of expression of mutant p53, oncogenic Ha-Ras still induced senescence with induction of p21 WAF1 and to a lesser extent, p16
INK4a (Serrano et al., 1997) . Furthermore, constitutive activation of MEK/MAPK mitogenic signaling in normal human fibroblasts reveals that there is induction of p53 and p16
INK4a with subsequent senescence (Lin et al., 1998) . Activation of Raf in IMR-90 fibroblasts induced premature senescence with induction of p21 WAF1 and p16
INK4a
. However, ablation of p53 (and diminished p21 WAF1 ) by HPV E6 did not alter Raf-1-induced senescence. Pharmacologic inhibition of Raf/MEK/MAPK pathway prevented senescence as well as p16
INK4a induction (Zhu et al., 1998) . Ras cannot induce p14 ARF in human fibroblasts with homozygous intragenic deletion of p16
INK4a but expressing functional p14 ARF . Cells acquire anchorage-independent growth but were not tumorigenic .
p16
INK4a is the most essential mediator for Ha-Ras G12V -induced senescence in human esophageal keratinocytes . Increased p16
INK4a is responsible for targeting of pRb, detected as a reduction in the hyperphosphorylated form of pRb in Ha-Ras G12V -transduced human esophageal keratinocytes. Western blotting did not reveal an increase in the hypophosphorylated form of pRb in Ha-Ras
G12V
-transduced cells (Figure 5 ), in concordance with previous reports that examined pRb status upon Ha-Ras G12V -induced senescence (Serrano et al., 1997; Lin et al., 1998; Ferbeyre et al., 2000; Harada et al., 2003; Mallette et al., 2004) . Such observations have led to the suggestion that the hypophosphorylated form of pRB exists in an insoluble nuclear fraction (Mallette et al., 2004) . In p16
INK4a
deficient human diploid fibroblasts retaining intact p14 ARF and p53 functions, there is resistance to Ras-induced senescence, and coexpression of Ha-Ras G12V and hTERT result in anchorage-independent cell growth (Huot et al., 2002; Drayton et al., 2003) . More recently, increased oncogenic Ras expression eventually induced p16
, thereby causing primary human fibroblasts to enter premature senescence (Deng et al., 2004) .
Transformation of primary human epidermal keratinocyte occurs with coexpression of Cdk4 and Ha-Ras G12V (Lazarov et al., 2002) . Cdk4 disruption renders primary mouse cells resistant to Ras-mediated transformation, leading to ARF/p53-independent senescence, while pRb inactivation fully restores the transformation potential of Cdk4-disrupted cells (Zou et al., 2002) . Also, cyclin D1 is required for transformation by Ras of certain rodent epithelial cell types (Yu et al., 2001) . Thus, it is likely that inactivation of the pRb pathway is required for human esophageal keratinocytes Figure 5 Immunoblot for cell cycle related proteins in human esophageal keratinocytes transduced Ha-Ras G12V . EPC2 cells (a) and EPC2-hTERT cells (b) expressing endogenous p53 (puro) or mutant p53 (p53 R175H ), and primary mouse esophageal keratinocytes (MEK) (c) isolated from wild-type or p53 À/À mice were transduced with Ha-Ras G12V (Ras) or an empty vector (zeo). The expression of each protein was examined at day 6 after retroviral infection except Cdk4 at day 3 as it was decreased transiently upon Ha-Ras G12V transduction and returned to the basal level by day 6
Ras-induced senescence in human esophageal keratinocytes M Takaoka et al to escape from Ha-Ras G12V -induced senescence and undergo transformation.
The differences between human and mouse cells in response to oncogenic Ras activation are intriguing. One possible explanation is that human cells have more redundant signaling pathways than mouse cells. Ha-Ras as well as Ki-Ras and N-Ras oncogenes induce growth arrest through activation of p21 WAF1 in K562 human erythroleukemia cells that are deficient for p53, p16
INK4a , p15 INK4b , and p14 ARF genes, suggesting the existence of redundant pathways and/or cell-type-specific signaling pathways (Delgado et al., 2000) In human cells, both E2F1 and p14 ARF induce premature senescence in fibroblasts with induction of p53 and p21 WAF1 (Dimri et al., 2000; Wei et al., 2001 ) Ectopic expression of E2F1 induces senescence through the ARF pathway. Ablation of p19 ARF in mouse leads to immortalization as well as promotion of ras-mediated transformation (Kamijo et al., 1997) .
Although Ras mutation is rare in esophageal cancer (Hollstein et al., 1988) , epidermal growth factor receptor (EGFR) is frequently overexpressed in this cancer and its precursor lesions, including hyperplasia and dysplasia (Yano et al., 1991; Itakura et al., 1994) . It is likely that EGFR overexpression may activate Ras-mediated signaling pathways. EGFR overexpression in primary human esophageal keratinocytes results in hyperplasia in organotypic culture , yet there is premature senescence in monolayer culture or cell-cycle arrest upon exposure to high concentrations of EGF (Takaoka, Nakagawa, and Rustgi, unpublished data) . It is tempting to speculate that EGFR provokes a Ras-mediated senescence response under certain conditions. In esophageal carcinoma, cyclin D1 is frequently overexpressed, while p53 and p16
INK4a functions are often lost by mutation or deletion . Cyclin D1 overexpression and p16
INK4a inactivation may lead to impaired pRb function, which allows esophageal keratinocytes to negate the growth inhibitory effect of activated EGFR.
In aggregate, we have found that Ras-mediated senescence may involve distinct mechanisms between human and mouse esophageal keratinocytes. Inactivation of the pRb pathway may be necessary for Ras to transform esophageal epithelial cells and overcoming senescence.
Materials and methods
Cell lines
Isolation of primary human esophageal keratinocytes (EPC2) was previously described . Cells were grown at 371C and 5% CO 2 with keratinocyte-SFM medium (KSFM) (Invitrogen, Carlsbad, CA, USA), supplemented with 40 mg/ml bovine pituitary extract (Invitrogen), 1.0 ng/ml epidermal growth factor (Invitrogen), 100 u/ml penicillin, 100 mg/ml streptomycin (Invitrogen). As these cells undergo senescence by 40-44 PDs, they were used for experiments before reaching to 10 PDs. EPC2 cells immortalized with ectopically expressed hTERT (EPC2-hTERT) was described elsewhere .
Primary mouse esophageal keratinocytes were isolated from wild-type (C57BL/6) and p53 À/À (B6.129S2-Trp53tm1Tyj) mice at the age of 3 months, respectively (The Jackson Laboratory, Bar Harbor, Maine, USA), as described previously (Opitz et al., 2002) . CaCl 2 concentration in the KSFM medium was optimized to 0.09 mM for human cells and 0.018 mM for mouse cells.
Retrovirus vectors and infection
cDNAs encoding mutated p53 (V143A and R175H) and Ha-Ras G12V were isolated by polymerase chain reaction using pCEP4-p53 V143A and pBSKp53 R175H plasmids (gift of Dr Wafik S El-Deiry) and pBabe-Ha-Ras (gift of Dr Scott W Lowe) as a template, and subcloned into the retroviral vectors of pBabe series (Morgenstern and Land, 1990) at their BamHI and EcoRI sites, resulting in creation of pBabe-puro-p53 V143A , pBabe-puro-p53
R175H
, and pBabe-zeo-Ha-Ras, respectively. The inserted region of the constructs was verified by DNA sequencing.
To produce replication-incompetent retroviruses, retroviral vectors were transfected into Phoenix-Ampho or Phoenix Eco packaging cell lines (gift of Dr Garry P Nolan) with Lipofectaminet2000 (Invitrogen) according to the manufacturer's instructions. The medium-containing virus was harvested 48 and 72 h after transfection, filtered (0.45 mm) (Pall Gelman Laboratory, Ann Arbor, MI, USA), and stored at À801C until use.
For infection, 0.5À1.5 Â 10 5 of cells were seeded per well of a six well tissue culture plate, and incubated overnight. Cells were exposed to 0.4 ml of the virus-containing medium added into 2 ml of fresh KSFM per well in the presence of 4 mg/ml of polybrene (Sigma-Aldrich Corp., St Louis, MO, USA). To infect cells seeded in 12-well plates, the medium volume was scaled down to half of that for six-well plates. The plate was centrifuged at 1800 r.p.m. at room temperature for 45 min., and then the medium was replaced with KSFM. At 36 h after infection, 0.5 mg/ml of puromycin (Sigma) was added for 5 days to establish cell lines expressing p53 mutants. For morphologic assessment and growth assays of cells that escaped Ras-induced senescence, cells were selected with 20 mg/ml of zeocin (Invitrogen) for 4 days following retroviral infection. However, selection for Ras-transduced cells was not carried out when cells were subjected to Western blotting and [ 3 H] thymidine incorporation assay to exclude the possibility that protein expression and cell proliferation are affected by the drug selection. In addition, these experiments were carried out within a week after retrovirus infection before control cells reach 100% confluency and undergo contact inhibition.
Morphologic changes upon Ha-Ras G12V transduction were assessed with phase contrast microscopy, and scored by counting photographed five high-power fields ( Â 200). H]thymidine (1 mCi/ml) (PerkinElmer Life Sciences Inc., Boston, MA, USA) added into each well. To harvest cells, cells were washed three times with cold phosphate-buffered saline, once with cold 10% trichloroacetic acid, and three times with 5% trichloroacetic acid. Cells were then lysed with 0.5 N NaOH on ice for 10 min., and neutralized with 0.5 N HCl. The cell lysate was supplemented with 10% trichloroacetic acid, incubated on ice for 20 min, and filtrated with glass microfiber filters (Whatman, Kent, ME, UK) using a sampling vacuum manifold (Millipore, Billerica, MA, USA).
The filters were rinsed three times with ethanol, dried at 801C for 45 min., and suspended in 10 ml of Ready Value Liquid Scintillation Cocktail (Beckman Coulter Inc., Fullerton, CA, USA) to measure radioactivity with an LS 6500 Multi-Purpose Scintillation Counter (Beckman Coulter).
SABG staining
To determine senescent cells, SABG assay was carried out with the Senescence b-Galactosidase Staining Kit (Cell Signaling Technology, Inc., Beverly, MA, USA) according to a manufacturer's protocol. Cells stained for SABG activity were scored by counting five high-power fields ( Â 200) under phase contrast microscopy.
Antibodies
The following primary antibodies were used: RAS10 (Cell Signaling) for Ras, DO-1 (Oncogene Research Products, San Diego, CA, USA) for p53, G175-1239 (BD Pharmingen, San Diego, CA, USA) for p16
INK4a
, G3-245 (Pharmingen) for pRb, 14P02 (Oncogene Research Products) for p14 ARF , DCS-6 for cyclin D1 (BD Pharmingen), EA10 for p21 WAF1 (Oncogene Research Products), H-22 (Santa Cruz, CA, USA) for Cdk4, C-21 (Santa Cruz) for Cdk6, clone 57 (BD Transduction Laboratories) for p27 KIP1 , and DMA1A þ DM1B (Neo Markers) for Tubulin.
Western blotting
Cells were washed with ice-cold phosphate-buffered saline and lysed with a RIPA buffer consisting of 10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Nonidet P-40 (NP-40), 0.1% SDS, 0.1% DOC, 1 mM EDTA, 2 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride, and Complete Mini, mixture of protease inhibitors (Roche Applied Science Indianapolis, IN, USA). After 30 min. on ice, the cell lysates were cleared by centrifugation at 14 000 r.p.m. at 41C for 15 min. Protein concentration was determined by the BCA protein assay (Pierce Biotechnology, Rockford, IL, USA). Protein (10-20 mg) was heat-denatured in NuPAGE lithium dodecyl sulfate sample buffer containing NuPAGE reducing agent (Invitrogen, Carlsbad, CA, USA) at 701C for 10 min. The protein samples were separated on a 4-12% SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Immobilon-P; Millipore Corp., Bedford, MA, USA). The membrane was blocked in 5% nonfat milk (Bio-Rad) in TBST (10 mM Tris, 150 mM NaCl, pH 8.0, and 0.1% Tween 20) for 1 h at room temperature. Membranes were probed with primary antibody diluted 1 : 1000 in 5% TBST milk overnight at 41C, washed three times in TBST, incubated with an anti-mouse or anti-rabbit horseradish peroxidase antibody diluted 1 : 3000 in TBST for 1 h at room temperature and then washed three times in TBST. The signal was visualized by an enhanced chemiluminescence solution (ECL Plus; Amersham Pharmacia Biotech) and was exposed to Eastman Kodak Co. X-Omat LS film. Densitometry of Western blots was performed using Scion Image Beta 4.02 Software (Frederick, MD, USA). Data was calibrated with b-actin or tubulin as a loding control, and shown as arbitrary units.
